At Jounce, we are driven by the desire to create long-lasting therapeutic options to transform the way cancer is treated. This is brought to life by our Cancer Hero Wall – a daily reminder of why we come to work each day and the potential impact we can have on patients’ lives.
We factor patients into every step of developing cancer therapies. We conduct biomarker analyses of patient populations in clinical trials with an aim to match the right immunotherapy to the right patients. We track patient outcomes from clinical trials and correlate this with biomarkers throughout clinical development, a process we call our reverse translational approach.
The potential benefit of our approach for cancer patients is two-fold: shorter development times to deliver novel therapies to patients with unmet needs and improved treatment outcomes.
It is our goal to make a meaningful and long-lasting impact on the lives of cancer patients.